Use access key #2 to skip to page content.
$145.60 17.60 (13.75%)
10/13/2008 4:02 PM

Alcon, Inc. (ACL)

CAPS Rating:
***

The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat diseases and disorders of the eye.

View All Commentary (ACL)

Recs

0

Avatar JMfrGeleen (< 20) Submitted: 6/29/08 3:26 PM : Outperform Start Price: $161.14 ACL Score: 15.27

Price target (1 year) $ 193

Report this Post Replies: 0 | Reply

Featured Broker Partners